-
1
-
-
44649162440
-
Are highly lipophilic volatile compounds expected to bioaccumulate with repeated exposures?
-
Andersen ME, Reddy MB, and Plotzke KP (2008) Are highly lipophilic volatile compounds expected to bioaccumulate with repeated exposures? Toxicol Lett 179:85-92.
-
(2008)
Toxicol Lett
, vol.179
, pp. 85-92
-
-
Andersen, M.E.1
Reddy, M.B.2
Plotzke, K.P.3
-
3
-
-
78349310347
-
Potential new drugs for human African trypanosomiasis: Some progress at last
-
Barrett MP (2010) Potential new drugs for human African trypanosomiasis: some progress at last. Curr Opin Infect Dis 23:603-608.
-
(2010)
Curr Opin Infect Dis
, vol.23
, pp. 603-608
-
-
Barrett, M.P.1
-
4
-
-
73149101270
-
Prediction of Vss from in vitro tissue-binding studies
-
Berry LM, Roberts J, Be X, Zhao Z, and Lin MH (2010) Prediction of Vss from in vitro tissue-binding studies. Drug Metab Dispos 38:115-121.
-
(2010)
Drug Metab Dispos
, vol.38
, pp. 115-121
-
-
Berry, L.M.1
Roberts, J.2
Be, X.3
Zhao, Z.4
Lin, M.H.5
-
5
-
-
0030591850
-
Anti-pneumocystis activity of bis-amidoximes and bis-O-alkylamidoximes prodrugs
-
DOI 10.1016/S0960-894X(96)00557-4, PII S0960894X96005574
-
Boykin DW, Kumar A, Hall JE, Bender BC, and Tidwell RR (1996) Anti-Pneumocystis carinii activity of bis-amidoximes and bis-O-alkylamidoxime prodrugs. Bioorg Med Chem 6:3017-3020. (Pubitemid 27015904)
-
(1996)
Bioorganic and Medicinal Chemistry Letters
, vol.6
, Issue.24
, pp. 3017-3020
-
-
Boykin, D.W.1
Kumar, A.2
Hall, J.E.3
Bender, B.C.4
Tidwell, R.R.5
-
6
-
-
0030806348
-
Physiological parameter values for physiologically based pharmacokinetic models
-
Brown RP, Delp MD, Lindstedt SL, Rhomberg LR, and Beliles RP (1997) Physiological parameter values for physiologically based pharmacokinetic models. Toxicol Ind Health 13:407-484. (Pubitemid 27314117)
-
(1997)
Toxicology and Industrial Health
, vol.13
, Issue.4
, pp. 407-484
-
-
Brown, R.P.1
Delp, M.D.2
Lindstedt, S.L.3
Rhomberg, L.R.4
Beliles, R.P.5
-
9
-
-
27644499431
-
Dicationic near-linear biphenyl benzimidazole derivatives as DNA-targeted antiprotozoal agents
-
DOI 10.1016/j.bmc.2005.07.024, PII S0968089605006863
-
Ismail MA, Batista-Parra A, Miao Y, Wilson WD, Wenzler T, Brun R, and Boykin DW (2005) Dicationic near-linear biphenyl benzimidazole derivatives as DNA-targeted antiprotozoal agents. Bioorg Med Chem 13:6718-6726. (Pubitemid 41571216)
-
(2005)
Bioorganic and Medicinal Chemistry
, vol.13
, Issue.24
, pp. 6718-6726
-
-
Ismail, M.A.1
Batista-Parra, A.2
Miao, Y.3
Wilson, W.D.4
Wenzler, T.5
Brun, R.6
Boykin, D.W.7
-
10
-
-
3543026365
-
Comparison of the use of liver models for predicting drug clearance using in vitro kinetic data from hepatic microsomes and isolated hepatocytes
-
DOI 10.1023/B:PHAM.0000026429.12114.7d
-
Ito K and Houston JB (2004) Comparison of the use of liver models for predicting drug clearance using in vitro kinetic data from hepatic microsomes and isolated hepatocytes. Pharm Res 21:785-792. (Pubitemid 39011301)
-
(2004)
Pharmaceutical Research
, vol.21
, Issue.5
, pp. 785-792
-
-
Ito, K.1
Houston, J.B.2
-
11
-
-
17644381224
-
Prediction of human drug clearance from in vitro and preclinical data using physiologically based and empirical approaches
-
DOI 10.1007/s11095-004-9015-1
-
Ito K and Houston JB (2005) Prediction of human drug clearance from in vitro and preclinical data using physiologically based and empirical approaches. Pharm Res 22:103-112. (Pubitemid 40558152)
-
(2005)
Pharmaceutical Research
, vol.22
, Issue.1
, pp. 103-112
-
-
Ito, K.1
Houston, J.B.2
-
12
-
-
34250749661
-
Model-based drug development
-
DOI 10.1038/sj.clpt.6100235, PII 6100235
-
Lalonde RL, Kowalski KG, Hutmacher MM, Ewy W, Nichols DJ, Milligan PA, Corrigan BW, Lockwood PA, Marshall SA, Benincosa LJ, et al. (2007) Model-based drug development. Clin Pharmacol Ther 82:21-32. (Pubitemid 46950619)
-
(2007)
Clinical Pharmacology and Therapeutics
, vol.82
, Issue.1
, pp. 21-32
-
-
Lalonde, R.L.1
Kowalski, K.G.2
Hutmacher, M.M.3
Ewy, W.4
Nichols, D.J.5
Milligan, P.A.6
Corrigan, B.W.7
Lockwood, P.A.8
Marshall, S.A.9
Benincosa, L.J.10
Tensfeldt, T.G.11
Parivar, K.12
Amantea, M.13
Glue, P.14
Koide, H.15
Miller, R.16
-
13
-
-
0030918716
-
Integration of in vitro data into allometric scaling to predict hepatic metabolic clearance in man: Application to 10 extensively metabolized drugs
-
DOI 10.1021/js960440h
-
Lave T, Dupin S, Schmitt C, Chou RC, Jaeck D, and Coassolo P (1997) Integration of in vitro data into allometric scaling to predict hepatic metabolic clearance in man: application to 10 extensively metabolized drugs. J Pharm Sci 86:584-590. (Pubitemid 27203406)
-
(1997)
Journal of Pharmaceutical Sciences
, vol.86
, Issue.5
, pp. 584-590
-
-
Lave, T..1
Dupin, S.2
Schmitt, C.3
Chou, R.C.4
Jaeck, D.5
Coassolo, P..6
-
14
-
-
0033016936
-
Interspecies pharmacokinetic comparisons and allometric scaling of napsagatran, a low molecular weight thrombin inhibitor
-
Lavé T, Portmann R, Schenker G, Gianni A, Guenzi A, Girometta MA, and Schmitt M (1999) Interspecies pharmacokinetic comparisons and allometric scaling of napsagatran, a low molecular weight thrombin inhibitor. J Pharm Pharmacol 51:85-91. (Pubitemid 29097274)
-
(1999)
Journal of Pharmacy and Pharmacology
, vol.51
, Issue.1
, pp. 85-91
-
-
Lave, T.1
Portmann, R.2
Schenker, G.3
Gianni, A.4
Guenzi, A.5
Girometta, M.-A.6
Schmitt, M.7
-
15
-
-
0032428485
-
Applications and limitations of interspecies scaling and in vitro extrapolation in pharmacokinetics
-
Lin JH (1998) Applications and limitations of interspecies scaling and in vitro extrapolation in pharmacokinetics. Drug Metab Dispos 26:1202-1212.
-
(1998)
Drug Metab Dispos
, vol.26
, pp. 1202-1212
-
-
Lin, J.H.1
-
16
-
-
0141619296
-
Physiologically based pharmacokinetic (PBPK) modeling of disposition of epiroprim in humans
-
DOI 10.1002/jps.10461
-
Luttringer O, Theil FP, Poulin P, Schmitt-Hoffmann AH, Guentert TW, and Lavé T (2003) Physiologically based pharmacokinetic (PBPK) modeling of disposition of epiroprim in humans. J Pharm Sci 92:1990-2007. (Pubitemid 37175630)
-
(2003)
Journal of Pharmaceutical Sciences
, vol.92
, Issue.10
, pp. 1990-2007
-
-
Luttringer, O.1
Theil, F.-P.2
Poulin, P.3
Schmitt-Hoffmann, A.H.4
Guentert, T.W.5
Lave, T.6
-
17
-
-
62949246259
-
Efficacy of the novel diamidine compound 2,5-bis(4-amidinophenyl)- furan-bis-O-methlylamidoxime (Pafuramidine, DB289) against Trypanosoma brucei rhodesiense infection in vervet monkeys after oral administration
-
Mdachi RE, Thuita JK, Kagira JM, Ngotho JM, Murilla GA, Ndung'u JM, Tidwell RR, Hall JE,and Brun R (2009) Efficacy of the novel diamidine compound 2,5-bis(4-amidinophenyl)- furan-bis-O-methlylamidoxime (Pafuramidine, DB289) against Trypanosoma brucei rhodesiense infection in vervet monkeys after oral administration. Antimicrob Agents Chemother 53:953-957.
-
(2009)
Antimicrob Agents Chemother
, vol.53
, pp. 953-957
-
-
Mdachi, R.E.1
Thuita, J.K.2
Kagira, J.M.3
Ngotho, J.M.4
Murilla, G.A.5
Ndung'U, J.M.6
Tidwell, R.R.7
Hall, J.8
Brun, R.9
-
18
-
-
34249037167
-
Pharmacokinetics and metabolism of the prodrug DB289 (2,5-bis[4-(N- methoxyamidino)phenyl]furan monomaleate) in rat and monkey and its conversion to the antiprotozoal/antifungal drug DB75 (2,5-bis(4-guanylphenyl)furan dihydrochloride)
-
DOI 10.1124/dmd.106.013391
-
Midgley I, Fitzpatrick K, Taylor LM, Houchen TL, Henderson SJ, Wright SJ, Cybulski ZR, John BA, McBurney A, Boykin DW, et al. (2007) Pharmacokinetics and metabolism of the prodrug DB289 (2,5-bis[4-(N-methoxyamidino)phenyl]furan monomaleate) in rat and monkey and its conversion to the antiprotozoal/ antifungal drug DB75 (2,5-bis(4-guanylphenyl)furan dihydrochloride). Drug Metab Dispos 35:955-967. (Pubitemid 46798606)
-
(2007)
Drug Metabolism and Disposition
, vol.35
, Issue.6
, pp. 955-967
-
-
Midgley, I.1
Fitzpatrick, K.2
Taylor, L.M.3
Houchen, T.L.4
Henderson, S.J.5
Wright, S.J.6
Cybulski, Z.R.7
John, B.A.8
McBurney, A.9
Boykin, D.W.10
Trendler, K.L.11
-
19
-
-
49649113402
-
Bayesian calibration of a physiologically based pharmacokinetic/ pharmacodynamic model of carbaryl cholinesterase inhibition
-
Nong A, Tan YM, Krolski ME, Wang J, Lunchick C, Conolly RB, and Clewell HJ 3rd (2008) Bayesian calibration of a physiologically based pharmacokinetic/pharmacodynamic model of carbaryl cholinesterase inhibition. J Toxicol Environ Health A 71:1363-1381.
-
(2008)
J Toxicol Environ Health A
, vol.71
, pp. 1363-1381
-
-
Nong, A.1
Tan, Y.M.2
Krolski, M.E.3
Wang, J.4
Lunchick, C.5
Conolly, R.B.6
Clewell III, H.J.7
-
20
-
-
77954970164
-
Diamidines for human African trypanosomiasis
-
Paine MF, Wang MZ, Generaux CN, Boykin DW, Wilson WD, De Koning HP, Olson CA, Pohlig G, Burri C, Brun R, et al. (2010) Diamidines for human African trypanosomiasis. Curr Opin Investig Drugs 11:876-883.
-
(2010)
Curr Opin Investig Drugs
, vol.11
, pp. 876-883
-
-
Paine, M.F.1
Wang, M.Z.2
Generaux, C.N.3
Boykin, D.W.4
Wilson, W.D.5
De Koning, H.P.6
Olson, C.A.7
Pohlig, G.8
Burri, C.9
Brun, R.10
-
21
-
-
52949140158
-
Formed and preformed metabolites: Facts and comparisons
-
Pang KS, Morris ME, and Sun H (2008) Formed and preformed metabolites: facts and comparisons. J Pharm Pharmacol 60:1247-1275.
-
(2008)
J Pharm Pharmacol
, vol.60
, pp. 1247-1275
-
-
Pang, K.S.1
Morris, M.E.2
Sun, H.3
-
22
-
-
34248680469
-
Physiologically based pharmacokinetics in drug development and regulatory science: A workshop report (Georgetown University, Washington, DC, May 29-30, 2002)
-
Rowland M, Balant L, and Peck C (2004) Physiologically based pharmacokinetics in drug development and regulatory science: a workshop report (Georgetown University, Washington, DC, May 29-30, 2002). AAPS Pharm Sci 6:E6.
-
(2004)
AAPS Pharm Sci
, vol.6
-
-
Rowland, M.1
Balant, L.2
Peck, C.3
-
23
-
-
28144457470
-
5 reductase
-
5 reductase. Drug Metab Dispos 33:1886-1893.
-
(2005)
Drug Metab Dispos
, vol.33
, pp. 1886-1893
-
-
Saulter, J.Y.1
Kurian, J.R.2
Trepanier, L.A.3
Tidwell, R.R.4
Bridges, A.S.5
Boykin, D.W.6
Stephens, C.E.7
Anbazhagan, M.8
Hall, J.E.9
-
24
-
-
77954362516
-
Sandwich-cultured hepatocytes: An in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity
-
Swift B, Pfeifer ND, and Brouwer KL (2010) Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity. Drug Metab Rev 42:446-471.
-
(2010)
Drug Metab Rev
, vol.42
, pp. 446-471
-
-
Swift, B.1
Pfeifer, N.D.2
Brouwer, K.L.3
-
25
-
-
33745948311
-
Hepatobiliary disposition of a drug/metabolite pair: Comprehensive pharmacokinetic modeling in sandwich-cultured rat hepatocytes
-
DOI 10.1124/jpet.106.102616
-
Turncliff RZ, Hoffmaster KA, Kalvass JC, Pollack GM, and Brouwer KL (2006) Hepatobiliary disposition of a drug/metabolite pair: comprehensive pharmacokinetic modeling in sandwich-cultured rat hepatocytes. J Pharmacol Exp Ther 318:881-889. (Pubitemid 44061264)
-
(2006)
Journal of Pharmacology and Experimental Therapeutics
, vol.318
, Issue.2
, pp. 881-889
-
-
Turncliff, R.Z.1
Hoffmaster, K.A.2
Kalvass, J.C.3
Pollack, G.M.4
Brouwer, K.L.R.5
-
26
-
-
33751543062
-
CYP4F enzymes are the major enzymes in human liver microsomes that catalyze the O-demethylation of the antiparasitic prodrug DB289 [2,5-bis(4- amidinophenyl)furan-bis-O-methylamidoxime]
-
DOI 10.1124/dmd.106.010587
-
Wang MZ, Saulter JY, Usuki E, Cheung YL, Hall M, Bridges AS, Loewen G, Parkinson OT, Stephens CE, Allen JL, et al. (2006) CYP4F enzymes are the major enzymes in human liver microsomes that catalyze the O-demethylation of the antiparasitic prodrug DB289 [2,5-bis(4-amidinophenyl)furan-bis-O- methylamidoxime]. Drug Metab Dispos 34:1985-1994. (Pubitemid 44837759)
-
(2006)
Drug Metabolism and Disposition
, vol.34
, Issue.12
, pp. 1985-1994
-
-
Wang, M.Z.1
Saulter, J.Y.2
Usuki, E.3
Cheung, Y.-L.4
Hall, M.5
Bridges, A.S.6
Loewen, G.7
Parkinson, O.T.8
Stephens, C.E.9
Allen, J.L.10
Zeldin, D.C.11
Boykin, D.W.12
Tidwell, R.R.13
Parkinson, A.14
Paine, M.F.15
Hall, J.E.16
-
27
-
-
35548936928
-
Human enteric microsomal CYP4F enzymes O-demethylate the antiparasitic prodrug pafuramidine
-
DOI 10.1124/dmd.107.016428
-
Wang MZ, Wu JQ, Bridges AS, Zeldin DC, Kornbluth S, Tidwell RR, Hall JE, and Paine MF (2007) Human enteric microsomal CYP4F enzymes O-demethylate the antiparasitic prodrug pafuramidine. Drug Metab Dispos 35:2067-2075. (Pubitemid 350005197)
-
(2007)
Drug Metabolism and Disposition
, vol.35
, Issue.11
, pp. 2067-2075
-
-
Wang, M.Z.1
Wu, J.Q.2
Bridges, A.S.3
Zeldin, D.C.4
Kornbluth, S.5
Tidwell, R.R.6
Hall, J.E.7
Paine, M.F.8
-
28
-
-
70349334612
-
New treatment option for second-stage African sleeping sickness: In vitro and in vivo efficacy of aza analogs of DB289
-
Wenzler T, Boykin DW, Ismail MA, Hall JE, Tidwell RR, and Brun R (2009) New treatment option for second-stage African sleeping sickness: in vitro and in vivo efficacy of aza analogs of DB289. Antimicrob Agents Chemother 53:4185-4192.
-
(2009)
Antimicrob Agents Chemother
, vol.53
, pp. 4185-4192
-
-
Wenzler, T.1
Boykin, D.W.2
Ismail, M.A.3
Hall, J.E.4
Tidwell, R.R.5
Brun, R.6
-
29
-
-
17644380257
-
Predicting drug disposition via application of BCS: Transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system
-
Wu CY and Benet LZ (2005) Predicting drug disposition via application of BCS: transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system. Pharm Res 22:11-23.
-
(2005)
Pharm Res
, vol.22
, pp. 11-23
-
-
Wu, C.Y.1
Benet, L.Z.2
-
30
-
-
79955021414
-
Mechanisms underlying differences in systemic exposure of structurally similar active metabolites: Comparison of two preclinical hepatic models
-
Yan GZ, Brouwer KL, Pollack GM, Wang MZ, Tidwell RR, Hall JE, and Paine MF (2011) Mechanisms underlying differences in systemic exposure of structurally similar active metabolites: comparison of two preclinical hepatic models. J Pharmacol Exp Ther 337:503-512.
-
(2011)
J Pharmacol Exp Ther
, vol.337
, pp. 503-512
-
-
Yan, G.Z.1
Brouwer, K.L.2
Pollack, G.M.3
Wang, M.Z.4
Tidwell, R.R.5
Hall, J.E.6
Paine, M.F.7
-
31
-
-
0036845742
-
Enhanced permeability of the antimicrobial agent 2,5-bis(4-amidinophenyl) furan across Caco-2 cell monolayers via its methylamidoxime prodrug
-
DOI 10.1023/A:1020957430400
-
Zhou L, Lee K, Thakker DR, Boykin DW, Tidwell RR, and Hall JE (2002) Enhanced permeability of the antimicrobial agent 2,5-bis(4-amidinophenyl)furan across Caco-2 cell monolayers via its methylamidoxime prodrug. Pharm Res 19:1689-1695. (Pubitemid 35305521)
-
(2002)
Pharmaceutical Research
, vol.19
, Issue.11
, pp. 1689-1695
-
-
Zhou, L.1
Lee, K.2
Thakker, D.R.3
Boykin, D.W.4
Tidwell, R.R.5
Hall, J.E.6
-
32
-
-
1942516882
-
Metabolites of an orally active antimicrobial prodrug, 2,5-bis(4-amidinophenyl)furan-bis-O-methylamidoxime, identified by liquid chromatography/tandem mass spectrometry
-
DOI 10.1002/jms.591
-
Zhou L, Thakker DR, Voyksner RD, Anbazhagan M, Boykin DW, Hall JE, and Tidwell RR (2004) Metabolites of an orally active antimicrobial prodrug, 2,5-bis(4-amidinophenyl)furanbis- O-methylamidoxime, identified by liquid chromatography/tandem mass spectrometry. J Mass Spectrom 39:351-360. (Pubitemid 38515348)
-
(2004)
Journal of Mass Spectrometry
, vol.39
, Issue.4
, pp. 351-360
-
-
Zhou, L.1
Thakker, D.R.2
Voyksner, R.D.3
Anbazhagan, M.4
Boykin, D.W.5
Hall, J.E.6
Tidwell, R.R.7
|